Big Changes to Come as Sermo and WorldOne Unify

WorldOne, a global leader in healthcare data collection, insights and intelligence, is preparing to ...

The History of Bio-Pharma Industry M&As, Lessons Learned and Trends to Watch

Many people believe the bio-pharma industry is oligopolistic, similar to the car or airline ...

Direct-to-Patient Models in Pharma—A Harbinger of Things to Come?

In recent years, pharmaceutical companies have implemented a few direct-to-patient models in the United ...

Leveraging Four Distinct Patient Archetypes to Drive Engagement

In the healthcare industry today, patients are empowered. They are more informed than ever ...

eyeforpharma’s 12th Annual Commercial Pharma Conference

  As the competition escalates and regulation changes in the healthcare ecosystem, pharma needs ...

Capturing the Moment

Summer is almost here and that means many of us are preparing to take ...

Change Is the Only Constant

For new cancer drugs, the world is changing. With costs expected to rise 20% ...

Putting Risk into Proper Perspective

A few years ago when my wife and I bought our home, we found ...

It’s The Young Adult Caregiver, Stupid!

Let this be a wake up call to the world, or at least anyone ...

My Other Life with Ali Martin

PM360 recently spoke to Ali Martin, Clinical Specialist and Marketer, Genentech, about her passion ...

Movers and Shakers May 2014

After a rocky rollout of the Affordable Care Act, then facing intense criticism about ...

The Pharma-Patient “Relationship” Alternative

I wrote about the pharma-patient “relationship” in my last column, and my belief that, ...

[sam_pro id=0_12 codes="true"]